Patient Participation

In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.

Harnessing advances in digital health technologies for a more precision-measured approach.

The potential of personal health records to bridge the gap between research and care.

Five proactive steps industry can take to optimize a patient's clinical trial experience.

Following a webinar on the use of a medical device in a migraine clinical trial, Mowlem caught up with ACT to discuss her biggest takeaways and what she is currently seeing in the digital trials space.

Systematic review of research articles sought to identify and characterize different technologies being used in clinical studies.

Webinar Date/Time: Tuesday, April 30, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Amplifying the size and diversity of participant pools in clinical trials enhances statistical power and increases the generalizability of study findings.

Results of cross-sectional study of 50 discharge summaries suggest a large language model can be used to increase their understandability.

In light of scant published data from sponsors and contract research organizations on site activation and recruitment challenges following the COVID-19 pandemic, the primary objective of this research is to revisit the results of recruitment and retention tactics in studies conducted in 2012 and 2019.

In this Applied Clinical Trials video interview, Julia Lakeland, Chief Product Officer, uMotif, talks about the ethical considerations that need to be addressed when implementing new technologies for collecting and analyzing patient data in clinical trials, while ensuring patient privacy.

In this Applied Clinical Trials video interview, Julia Lakeland, Chief Product Officer, uMotif, discusses new technologies that can help personalize the clinical trial experience for diverse patient populations.

In this Applied Clinical Trials video interview, Julia Lakeland, Chief Product Officer, uMotif, discusses the development of new technologies helping to foster trust and informed decision-making throughout the clinical trial process.

Transparent and detailed communication throughout the research process is key for effectively recruiting and retaining patients for clinical trials.

In this Applied Clinical Trials video interview, Julia Lakeland, Chief Product Officer, uMotif, discusses what kinds of technologies can be developed to improve patient engagement while still maintaining data integrity.

Exploring a human-centered, holistic approach for equitable trial outcomes.

Truly moving the needle in clinical trial diversity comes down to embracing two fundamental pieces of the DE&I puzzle.

Spotlight on poor compliance, access, and usefulness of trial results summaries.

Webinar Date/Time: Thu, Mar 28, 2024 12:00 PM EDT

With inequalities in palliative care provisions, recent study seeks to create a more equitable, diverse, and inclusive framework based on Patient and Public Involvement.

A framework to understand the different approaches of trial matching solutions and the major operational and workflow challenges that all matching solutions share.

An overview of patient perceptions of cancer clinical trials and the consent process among those who are currently enrolled in, or who recently completed, a cancer clinical trial.

Webinar Date/Time: Thursday, March 14th, 2024 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET

Webinar Date/Time: Wed, Mar 27, 2024 11:00 AM EDT

Leveraging a “diversity by design” approach can build patient narratives and optimize protocols from the onset.